The cytoarchitecture of nuclei in the diencephalon and the distribution of acetylcholinesterase (AChE) in the diencephalon and optic tectum were analyzed in the longnose gar, Lepisosteus osseus, a non-teleost actinopterygian fish. Nuclei were identified in the preoptic area, thalamus, posterior tubercle, hypothalamus, synencephalon, and pretectum which are homologous to like-named nuclei in teleosts and other non-teleost actinopterygians. Of particular note, a nucleus in the rostral diencephalon, nucleus rostrolateralis, which has previously been identified only in the osteoglossomorph Pantodon, is present in the longnose gar. The posterior pretectal nucleus, previously identified in teleosts and in the bowfin Amia, is also present in gars. The small size of the posterior pretectal nucleus in gars supports the hypothesis that this nucleus was small plesiomorphically. The distribution of AChE in the diencephalon and optic tectum corresponds in most respects to that found in teleosts. The superficial pretectal nuclei, including the posterior pretectal nucleus, are strongly positive for AChE. In contrast, most of the nuclei within the preglomerular complex are negative for AChE. Acetylcholinesterase is present in some of the fibers in the optic tracts and in most retinorecipient nuclei, as well as in some other nuclei and tracts.

Keywords:
Acetylcholinesterase, Diencephalon, Pretectum, Optic tectum, Fish, Cytoarchitecture
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.